Press Releases

Press Releases


Study demonstrates adherence to disease-modifying therapies in pregnant MS patients can reduce hospitalization events

ORLANDO, Fla., March 1, 2021 – AllianceRx Walgreens Prime recently announced results from research analyzing data of females with multiple sclerosis (MS) who became pregnant, and the impact of adherence to their disease-modifying therapies (DMTs) on hospital utilization and cost.

Read More >

Media Contact

Adrienne Foley
Corporate Communications Manager
[email protected]

Connect with us 24/7